Table 2.
Presenting diagnosis and indications for advanced respiratory support.
| |||
---|---|---|---|
CHARACTERISTIC | OVERALL | INTUBATION | NIPPV |
| |||
N = 46 | N = 27 (58.7%) | N = 23 (50.0%) | |
| |||
Presumed diagnosis at time of respiratory supporta, n (%) | |||
| |||
Cardiovascular | 16 (34.8%) | 4 (14.8%) | 13 (56.5%) |
| |||
Cardiogenic pulmonary edema | 12 (26.1%) | 1 (3.7%) | 11 (47.8%) |
| |||
Cardiogenic shock | 3 (6.5%) | 0 (0.0%) | 3 (13.0%) |
| |||
Pulmonary embolism | 1 (2.2%) | 0 (0.0%) | 1 (4.3%) |
| |||
Hypovolemic shock | 3 (6.5%) | 3 (11.1%) | 1 (4.3%) |
| |||
Hypertensive emergency | 2 (4.3%) | 0 (0.0%) | 2 (8.7%) |
| |||
Respiratory | 10 (21.7%) | 5 (18.5%) | 6 (26.1%) |
| |||
Severe asthma | 6 (13.0%) | 4 (14.8%) | 3 (13.0%) |
| |||
Acute respiratory distress syndrome | 2 (4.3%) | 1 (3.7%) | 1 (4.3%) |
| |||
Pulmonary hemorrhage | 1 (2.2%) | 0 (0.0%) | 1 (4.3%) |
| |||
COPD | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| |||
Infectious | 13 (28.3%) | 12 (44.4%) | 3 (13.0%) |
| |||
Pneumonia or pulmonary sepsis | 7 (15.2%) | 6 (22.2%) | 3 (13.0%) |
| |||
Bacterial infection (unspecified) | 2 (4.3%) | 2 (7.4%) | 0 (0.0%) |
| |||
Hematological | 2 (4.3%) | 2 (7.4%) | 0 (0.0%) |
| |||
Neurological | 2 (4.3%) | 2 (7.4%) | 0 (0.0%) |
| |||
Endocrine | 3 (6.5%) | 3 (11.1%) | 0 (0.0%) |
| |||
Other | 3 (6.5%) | 2 (7.4%) | 1 (4.3%) |
| |||
Indication for advanced respiratory supporta, n (%) | |||
| |||
Hypoxia | – | 11 (40.7%) | 15 (65.2%) |
| |||
CO2 retention | – | 4 (14.8%) | 0 (0.0%) |
| |||
Respiratory distress | – | 2 (7.4%) | 8 (34.8%) |
| |||
Respiratory arrest | – | 8 (29.6%) | – |
| |||
Cardiac arrest | – | 2 (7.4%) | – |
| |||
Airway protection | – | 12 (44.4%) | – |
| |||
Airway obstruction | – | 3 (11.1%) | – |
| |||
Other | – | 1 (3.7%) | 0 (0.0%) |
|
COPD, chronic obstructive pulmonary disease. CO2, carbon dioxide.
a Multiple presumed diagnoses and indications for respiratory support could be selected for a patient.